Vilanterol
Overview
Vilanterol is an ultra-long-acting β₂-adrenoceptor agonist which was approved in May 2013 in combination with fluticasone furoate for sale as Breo Ellipta by GlaxoSmithKline for the treatment of chronic obstructive pulmonary disease (COPD). The combination is also approved for the treatment of asthma in Canada, Europe, Japan and New Zealand.[1–4] WP
Vilanterol is available in following combinations: WP
with inhaled corticosteroid fluticasone furoate—fluticasone furoate/vilanterol (trade names Breo Ellipta (U.S., NZ), Relvar Ellipta (EU, RU, JPN)) WP
with muscarinic antagonist umeclidinium bromide—umeclidinium bromide/vilanterol (trade name Anoro Ellipta) WP
with inhaled corticosteroid fluticasone furoate and muscarinic antagonist umeclidinium bromide—fluticasone furoate/umeclidinium bromide/vilanterol (trade name Trelegy Ellipta) WP
Chemistry
- Formula
- C24H33Cl2NO5 PC
- CAS number
- 503068-34-6 PC
- Molar mass (g/mol)
- 486.4 PC
- IUPAC name (computed by PubChem)
- 4-
[(1R) PC- 2- [6- [2- [(2, 6- dichlorophenyl) methoxy] ethoxy] hexylamino] - 1- hydroxyethyl] - 2- (hydroxymethyl) phenol - SMILES
- C1=CC(=C(C(=C1)
Cl) PCCOCCOCCCCCCNC[C@@H] (C2=CC(=C(C=C2) O) CO) O) Cl - InChIKey
- DAFYYTQWSAWIGS-
DEOSSOPVSA- PCN - PubChem CID
- 10184665
Harm reduction information
No harm reduction data is on file for this compound yet. That means no dose, timing or combination data from PsychonautWiki or TripSit. Please don't guess a dose from similar compounds. If you have taken it and feel unwell, contact emergency services or a poison control center.
User reports
Erowid erowid.org
ListingsBluelight bluelight.org
ListingsReddit reddit.com
ListingsPop culture
No references added yet.
Add a reference
Registered users can add songs, films, books, shows, games and art about this substance. Link a source that names the substance, such as the work's Wikipedia article, a review or an interview, not only the work itself. Entries are voted on and moderated like every other value on this page.
Opens when accounts launch.
Sources
- Journal / agency FDA approves Breo Ellipta to treat chronic obstructive pulmonary disease
- Journal / agency McKeage K. Fluticasone furoate/vilanterol: a review of its use in chronic obstructive pulmonary disease. Drugs. September 2014. doi:10.1007/s40265-014-0269-6 · PMID 25074268
- Journal / agency Syed YY. Fluticasone furoate/vilanterol: a review of its use in patients with asthma. Drugs. March 2015. doi:10.1007/s40265-015-0354-5 · PMID 25648266
- Other Zealand (www.bka.co.nz), Site designed and developed by bka interactive ltd, Auckland, New. Fluticasone and vilanterol | Health Navigator NZ. 22 June 2019
Text and values on this page are quoted from Wikipedia (CC BY-SA 4.0), PubChem (public domain). Each value links to the exact revision it came from.